News | December 21, 2012

First Implants Made for Nanostim Leadless Pacemakers

December 21, 2012 — Nanostim Inc. announced the first successful implants of a leadless pacemaker in a series of 11 patients at Homolka Hospital in Prague, Czech Republic. The leadless pacemakers were implanted by Drs. Petr Neuzil, head of cardiology at Homolka Hospital, and Vivek Reddy, director of electrophysiology at Mount Sinai Hospital in New York. The patients were enrolled in the company’s LEADLESS study, which is designed to examine the safety and effectiveness of the first totally self-contained, leadless pacemaker. The study is a prospective, single-arm, multicenter study that will be conducted in up to eight centers in Europe to gather data in support of CE mark approval.

In a conventional pacemaker procedure, an incision is made in the upper chest and one or more leads are guided through a vein into the heart. The pacemaker is then connected to the lead(s) and inserted beneath the skin, and the incision is closed. Nanostim utilizes a catheter-based approach through the femoral vein delivering a self-contained leadless pacemaker directly into the heart without the need for a surgical pocket or lead.

“Nanostim’s leadless cardiac pacemaker represents a paradigm shift in the treatment of bradycardia patients and one of the most significant advances in pacemaker technology in decades. This novel miniaturization of the pacemaker changes the delivery of pacemaker therapy from a surgical procedure with a chest wall incision to a non-surgical percutaneous one. We look forward to offering this important technology to our patients,” said Reddy.

Added Neuzil, “I am impressed with the ease of implantation of the pacemaker and particularly with the intuitive controls on the delivery catheter. The procedural times were short, and the pacemaker performed just like a conventional pacemaker.”

The Nanostim approach is designed to improve patient comfort by giving the physician a simplified, less invasive option, permitting implantation as an outpatient, eliminating the visible lump and scar at a conventional pacemaker’s pectoral implant site, and removing the need for activity restrictions to prevent dislodgement after implantation of a conventional lead. Because this new approach eliminates the surgical pocket and lead, the device has the potential to reduce overall complications, specifically infection and lead failure.

“We’re excited to achieve this important milestone and move closer to offering this innovative technology to patients around the world,” said Drew Hoffmann, CEO of Nanostim Inc. “As we take another step towards commercialization, we continue to value the support of our investors, including St. Jude Medical, a proven global leader in the care of CRM patients.”

Nanostim is an emerging medical device manufacturer that is developing a self-contained leadless cardiac pacemaker system. The company is backed by InterWest Partners, US Venture Partners, Emergent Medical Partners, Life Science Angels and St. Jude Medical, which has an exclusive option to purchase Nanostim upon the completion of certain development milestones.

Related Content

Videos | Pacemakers | February 13, 2020
This video illustrates how the Micra AV leadless pacemaker is delivered via catheter and enables atrioventricular (AV
The Micra AV leadless pacemaker
News | Pacemakers | February 13, 2020
February 13, 2020 — The U.S.
Results from the MARVEL 2 (Micra Atrial Tracking Using A Ventricular accELerometer) study shows that an investigational set of algorithms in the Medtronic Micra Transcatheter Pacing System (TPS) significantly improves synchrony and cardiac function in patients with atrioventricular (AV) block. This is an impaired electrical conduction between the chambers of the heart.
News | Pacemakers | November 15, 2019
(February 2020 update — the results of this trial led to the FDA clearnace of the Micra AV device in January 2020
Co-principal investigator professor Aydin Babakhani at the UCLA Integrated Sensor Laboratory holds an earlier version of the prototype leadless, wireless amnd batteryless pacemaker. Photo Credit: Cody Duty, Texas Medical Center.

Co-principal investigator professor Aydin Babakhani at the UCLA Integrated Sensor Laboratory holds an earlier version of the prototype leadless, wireless and battery-less pacemaker. Photo Credit: Cody Duty, Texas Medical Center.

News | Pacemakers | November 13, 2019
FDA Warns of Premature Battery Depletion in Some Medtronic Pacemakers
News | Pacemakers | May 07, 2019 | Dave Fornell, Editor
The U.S. Food and Drug Administration (FDA) issued a safety communication to alert healthcare providers and patients...
Artificial Intelligence Can Improve Emergency X-ray Identification of Pacemakers
News | Pacemakers | March 29, 2019
A research team from Imperial College London believes a new software could speed up the diagnosis and treatment of...
Medtronic Recalls Dual Chamber Pacemakers
News | Pacemakers | February 20, 2019
Medtronic is recalling its dual chamber implantable pulse generators (IPGs) due to the possibility of a software error...
CHLA/USC Team Designs Novel Micropacemaker

Model of the human heart with microprocessor located in the pericardial sac and attached to the left ventricle. Graphic courtesy of Business Wire.

News | Pacemakers | June 29, 2018
Investigators at Children's Hospital Los Angeles (CHLA) and the University of Southern California (USC) have...
Permanent Pacing Effective for Older Patients With Syncope and Bifascicular Block
News | Pacemakers | May 24, 2018
Syncope with bifascicular block may be caused by intermittent complete heart block, but competing diagnoses may coexist...
Novel Mechanical Sensor in Medtronic Micra Transcatheter Pacing System Detects Atrial Contractions, Restores AV Synchrony
News | Pacemakers | May 24, 2018
New clinical study results demonstrate that an investigational algorithm, utilizing the accelerometer signal in the...